Biocept, Inc.

NasdaqCM:BIOC 주식 보고서

시가총액: US$2.7m

Biocept 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Antonino Morales

최고 경영자

US$781.6k

총 보상

CEO 급여 비율46.8%
CEO 임기less than a year
CEO 소유권n/a
경영진 평균 재임 기간3.9yrs
이사회 평균 재임 기간6.1yrs

최근 관리 업데이트

Recent updates

Biocept, Inc. (NASDAQ:BIOC) Shares Fly 48% But Investors Aren't Buying For Growth

Apr 17
Biocept, Inc. (NASDAQ:BIOC) Shares Fly 48% But Investors Aren't Buying For Growth

Statutory Earnings May Not Be The Best Way To Understand Biocept's (NASDAQ:BIOC) True Position

Nov 23
Statutory Earnings May Not Be The Best Way To Understand Biocept's (NASDAQ:BIOC) True Position

Just In: One Analyst Has Become A Lot More Bullish On Biocept, Inc.'s (NASDAQ:BIOC) Earnings

Aug 19
Just In: One Analyst Has Become A Lot More Bullish On Biocept, Inc.'s (NASDAQ:BIOC) Earnings

Shareholders Will Probably Hold Off On Increasing Biocept, Inc.'s (NASDAQ:BIOC) CEO Compensation For The Time Being

Jul 03
Shareholders Will Probably Hold Off On Increasing Biocept, Inc.'s (NASDAQ:BIOC) CEO Compensation For The Time Being

Biocept and CLEARED4 ink collaboration agreement

Jun 09

Biocept enters COVID-19 testing partnership

Apr 28

Biocept (NASDAQ:BIOC) Shareholders Have Enjoyed An Impressive 104% Share Price Gain

Mar 13
Biocept (NASDAQ:BIOC) Shareholders Have Enjoyed An Impressive 104% Share Price Gain

We're Keeping An Eye On Biocept's (NASDAQ:BIOC) Cash Burn Rate

Jan 26
We're Keeping An Eye On Biocept's (NASDAQ:BIOC) Cash Burn Rate

Biocept, Inc. (NASDAQ:BIOC): Is Breakeven Near?

Dec 22
Biocept, Inc. (NASDAQ:BIOC): Is Breakeven Near?

Biocept's assays viable and sensitive for detecting tumor cells and biomarkers

Nov 20

Biocept +4% on COVID-19 testing update

Nov 12

CEO 보상 분석

Antonino Morales 의 보수는 Biocept 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2023n/an/a

-US$31m

Mar 31 2023n/an/a

-US$37m

Dec 31 2022US$782kUS$366k

-US$32m

Sep 30 2022n/an/a

-US$25m

Jun 30 2022n/an/a

-US$16m

Mar 31 2022n/an/a

-US$8m

Dec 31 2021US$57kn/a

-US$3m

보상 대 시장: Antonino 의 총 보상 ($USD 781.63K )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 650.80K ).

보상과 수익: 회사가 수익성이 없는 동안 Antonino 의 보상이 증가했습니다.


CEO

Antonino Morales (67 yo)

less than a year

테뉴어

US$781,631

보상

Mr. Antonino Morales serves as Director of Biocept, Inc., since July 20, 2021 and served as its Interim Chief Financial Officer since February 15, 2022 until June 21, 2023 and serves as its Chief Executive...


리더십 팀

이름위치테뉴어보상소유권
Antonino Morales
CEO, President & Directorless than a yearUS$781.63k데이터 없음
Darrell Taylor
Chief Legal Officer1.7yrsUS$773.28k0%
$ 0
Soon Hahn
Founder26.8yrs데이터 없음데이터 없음
Rob Walsh
VP & Controllerless than a year데이터 없음데이터 없음
Philippe Marchand
Chief Operating Officer1.6yrs데이터 없음데이터 없음
Pavel Tsinberg
Director of Technology Development6.1yrs데이터 없음데이터 없음
David Moskowitz
Vice President of Strategy & Corporate Communications7yrs데이터 없음데이터 없음
Veena Singh
Senior Medical Director8.8yrsUS$577.58k데이터 없음

3.9yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 관리: BIOC 의 관리팀은 경험 ( 3.9 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Antonino Morales
CEO, President & Director2.3yrsUS$781.63k데이터 없음
Ivor Royston
Independent Director13.8yrsUS$65.21k0.000080%
$ 2.1
Linda Rubinstein
Independent Director2.3yrsUS$57.26k0%
$ 0
Quyen Dao-Haddock
Independent Directorless than a yearUS$13.32k0%
$ 0
Marsha Chandler
Independent Vice Chairman of the Board9.9yrsUS$70.21k0.000040%
$ 1.1
Fred Hirsch
Member of Clinical Advisory Boardno data데이터 없음데이터 없음
Bruce Gerhardt
Independent Chairman of the Board13yrsUS$67.71k0.00057%
$ 15.3

6.1yrs

평균 재임 기간

72yo

평균 연령

경험이 풍부한 이사회: BIOC 의 이사회경험(평균 재직 기간 6.1 년)으로 간주됩니다.